Ocular Therapeutix (OCUL) Misses Q3 EPS by 1c

Ocular Therapeutix (NASDAQ: OCUL) reported Q3 EPS of ($0.54), $0.01 worse than the analyst estimate of ($0.53). Revenue for the quarter came in at $523 thousand versus the consensus estimate of $510 thousand.

For earnings history and earnings-related data on Ocular Therapeutix (OCUL) click here.

You May Also Be Interested In

• The Gap, Inc. (GAP) Tops Q2 EPS by 3c
• SolarEdge (SEDG) PT Lowered to $31 at Jefferies, 'We see shares as an unappealing short, not a compelling long'
• Autodesk (ADSK) Tops Q2 EPS by 18c, Beats on Revenue; Offers FY27 EPS Guidance